Nat. Rev. Endocrinol. doi: /nrendo

Slides:



Advertisements
Similar presentations
1 Chapter 60 Neurobiology of Severe Mood and Anxiety Disorders Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights.
Advertisements

BIOC DR. TISCHLER LECTURE 32
SIGNAL TRANSDUCTION: INSULIN
Signaling and the Signal Transduction Cascade. Question?????? External Stimulus Inside cell Nucleus, Gene transcription Other cellular effects.
Insulin Receptor. Pancreas is the endocrine organ that produces and releases insulin.
Responses of Cells to Environmental Influences By Kari Edge.
Cell Signaling II Signal Transduction pathways
CHAPTER 13 Insulin Signaling. Figure 13.1 – General mechanism of signal transduction across a membrane Steps involved: 1. Release of primary messenger.
Specialized signaling pathways 1: RTK associated pathways
PANCREAS- ya herd? Insulin: lipids or brotein?  Insulin is a peptide-based hormone.
Diabetes Marta Plumhoff, Samantha Morley, Michael Hirsch, Eleni Kondak
Transduction of Extracellular Signals Specific receptors in plasma membranes respond to external chemicals (ligands) that cannot cross the membrane: hormones,
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Improving Glucose Metabolism With Resveratrol in.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Adrenergic-Fatty Acid Load in Heart Failure J.
Insulin and glucose uptake in muscle and adipose tissue
Unit 1 Lesson 6 Activity 3- Insulin and the Human Body
An applied electric field induces polarized activation of PI3 kinase
Facilitated Diffusion
Figure 2 Inflammatory pathways affecting hepatic insulin resistance
Communication within Multicellular Organisms
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
Figure 2 The unfolded protein response
Figure 4 Simplified T cell and antigen presenting
You have identified a novel cytoplasmic protein
Insulin Pork Drugbank ID :DB00071 Molecular Weight (Daltons) :5795.6
Figure 1 Signalling pathways involved in muscle wasting in heart failure Figure 1 | Signalling pathways involved in muscle wasting in heart failure. Pathways.
Inositol as putative integrative treatment for PCOS
All roads lead to FoxO Cell Metabolism
The Incretins and β-Cell Health: Contrasting Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 as a Path to Understand Islet Function.
Insulin Beef Drugbank ID : DB09456 Molecular Weight (Daltons) :5733.5
Leptin and insulin signalling pathways in the Arc.
Figure 1 mTOR pathway activation
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 A schematic representation of the HER2 signalling pathway
Figure 2 Oestrogen receptor signalling pathways
Figure 2 Intracellular actions of metformin
Erythropoietins: A common mechanism of action
Figure 1 ER stress and associated lines of defence
Figure 1 Control of hepatic gluconeogenesis
Figure 2 Control of hepatic glycogen metabolism
Figure 3 Physiological regulation of autophagy in the heart
Nat. Rev. Nephrol. doi: /nrneph
Volume 92, Issue 5, Pages (March 1998)
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Vascular dysfunction in diabetes mellitus
Lithium: Mechanism of Action
Figure 1 The insulin signalling pathway
The paradox of neuronal insulin action and resistance in the development of aging- associated diseases  Sophie M. Steculorum, Maite Solas, Jens C. Brüning 
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Anemia management and chronic renal failure progression
Estrogen Receptors and the Metabolic Network
Figure 1 Oxidative phosphorylation
Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus  John E. Gerich, MD  Mayo Clinic Proceedings 
Insulin Signaling: GLUT4 Vesicles Exit via the Exocyst
Figure 1 Exercise enhances insulin sensitivity
Craig S. Stump, MD, PhD, Marc T. Hamilton, PhD, James R. Sowers, MD 
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Figure 1 Altered modes of cAMP signalling at PTHR1
Volume 104, Issue 4, Pages (February 2001)
Summary of the new mechanistic findings of the present study.
Figure 1 Thyroid hormone effects on hepatic lipid metabolism
Brief Review – Growth Factors and Receptors
Cell Signaling by Receptor Tyrosine Kinases
Insulin-stimulated glucose and potassium transport in skeletal muscle.
The cell model illustrates β2-adrenergic and insulin-mediated regulatory pathways for K+ uptake. β2-Adrenergic and insulin both lead to K+ uptake by stimulating.
Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2015.194 Figure 1 Potential sites of action of statins on cellular insulin action identified from in vitro studies Figure 1 | Potential sites of action of statins on cellular insulin action identified from in vitro studies. Insulin receptor tyrosine kinase is activated by insulin, which results in the tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1). The serine–threonine kinase AKT is subsequently activated, which facilitates the movement of storage vesicles containing glucose transporter type 4 (GLUT4) to the cell membrane. The transmembrane protein, GLUT4, enables glucose to enter the cell. Tyrosine phosphorylated IRS-1 has binding sites for key signalling proteins, including the p85 and p110 subunits of phosphatidylinositol 3-kinase, which through activation of the AKT and protein kinase 3 (PKC) cascades has a major role in insulin function. Activated AKT induces glycogen synthesis through inhibition of glycogen synthase kinase 3β (GSK3β), protein synthesis and cell survival by inhibiting Bcl-2-associated death promoter (BAD; a proapoptotic factor), forkhead box protein O1 (FOXO1; a transcription factor) and GSK3β. P, phosphate group; PI, phosphatidylinositol. Reprinted from Banach, M. et al. Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance. Curr. Pharm. Des. 19, 4904–4912 (2013) © with permission from Bentham Science. Betteridge, D. J. & Carmena, R. (2015) The diabetogenic action of statins — mechanisms and clinical implications Nat. Rev. Endocrinol. doi:10.1038/nrendo.2015.194